The Seaver Autism Center for Research and Treatment - Assessment Core

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

ADNP, also known as Activity Dependent Neuroprotective Protein, is a rare neurodevelopmental disorder caused by mutations encompassing the ADNP gene on chromosome 20. Clinically, ADNP syndrome is characterized by intellectual disability and global developmental delay. This study seeks to characterize ADNP-related neurodevelopmental disorders using a number of genetic, medical and neuropsychological measures.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
View:

• Eligible participants must have a documented variant affecting the ADNP gene that the research team determines to be likely or definitely pathogenic.

• Eligible participants must be at least 2 years of age.

Locations
United States
New York
The Seaver Autism Center for Research and Treatment
RECRUITING
New York
Contact Information
Primary
Tess Levy
tess.levy@mssm.edu
212-241-5290
Time Frame
Start Date: 2017-11-14
Estimated Completion Date: 2027-03
Participants
Target number of participants: 30
Related Therapeutic Areas
Sponsors
Collaborators: Autism Science Foundation, The Seaver Foundation, Research Foundation for Mental Hygiene, Inc.
Leads: Icahn School of Medicine at Mount Sinai

This content was sourced from clinicaltrials.gov